ZA80817B - Process for the manufacture of lh-rh and lh-rh analogs using glu-his(dnp)-oh - Google Patents

Process for the manufacture of lh-rh and lh-rh analogs using glu-his(dnp)-oh

Info

Publication number
ZA80817B
ZA80817B ZA00800817A ZA80817A ZA80817B ZA 80817 B ZA80817 B ZA 80817B ZA 00800817 A ZA00800817 A ZA 00800817A ZA 80817 A ZA80817 A ZA 80817A ZA 80817 B ZA80817 B ZA 80817B
Authority
ZA
South Africa
Prior art keywords
dnp
glu
analogs
manufacture
Prior art date
Application number
ZA00800817A
Other languages
English (en)
Inventor
W Koenig
V Teetz
G Jaeger
R Geiger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA80817B publication Critical patent/ZA80817B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA00800817A 1979-02-14 1980-02-13 Process for the manufacture of lh-rh and lh-rh analogs using glu-his(dnp)-oh ZA80817B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2905502A DE2905502C2 (de) 1979-02-14 1979-02-14 Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin

Publications (1)

Publication Number Publication Date
ZA80817B true ZA80817B (en) 1981-01-28

Family

ID=6062835

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00800817A ZA80817B (en) 1979-02-14 1980-02-13 Process for the manufacture of lh-rh and lh-rh analogs using glu-his(dnp)-oh

Country Status (13)

Country Link
US (1) US4275001A (xx)
EP (1) EP0014911B1 (xx)
JP (2) JPS55111449A (xx)
AR (1) AR227386A1 (xx)
AT (1) ATE2316T1 (xx)
AU (1) AU532335B2 (xx)
CA (1) CA1144160A (xx)
DE (2) DE2905502C2 (xx)
DK (1) DK148085C (xx)
ES (1) ES488382A1 (xx)
HU (1) HU182067B (xx)
IL (1) IL59362A (xx)
ZA (1) ZA80817B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
DE3421303A1 (de) * 1984-06-08 1985-12-12 Hoechst Ag, 6230 Frankfurt Salze aus 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazin und amino-verbindungen
GB2187461A (en) * 1986-02-03 1987-09-09 Medical Res Council Monitoring method for the synthesis of a linear of amino acid residues
AT388918B (de) * 1987-10-08 1989-09-25 Hoechst Ag Aminosaeure-oobt-ester
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
RU2442791C1 (ru) * 2010-07-08 2012-02-20 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения бусерелина и промежуточные соединения для его получения

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2211101A1 (de) * 1972-03-08 1973-09-13 Hoechst Ag Neues dekapeptid mit hormon-wirkung
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
US3888836A (en) * 1972-05-30 1975-06-10 Merck & Co Inc Pentapeptide intermediate of lhrh and derivatives thereof
US3931138A (en) * 1973-03-13 1976-01-06 Abbott Laboratories N-carbobenzoxy-pyroglutamyl-histidine
IT1045531B (it) * 1973-10-19 1980-05-10 Serono Ist Farm Prodesso per la preparazione di l.piroslutamil.l.istidil.l.prolinamide sintetica,trh
US4083967A (en) * 1973-11-01 1978-04-11 Burroughs Wellcome Co. Nona- and decapeptides
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
ZA754724B (en) * 1974-08-28 1976-06-30 Hoffmann La Roche Amide
NZ181036A (en) * 1975-06-12 1978-12-18 A Schally Luteinising hormone releasing hormone analogues and intermediates therefor
GB1559610A (en) * 1975-10-31 1980-01-23 Armour Pharma Synthesis of peptides
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
HU177134B (en) * 1977-07-18 1981-07-28 Richter Gedeon Vegyeszet Process for preparing angiotensin ii analogues containing alpha-hydroxy-acid in position 1 with angiotensin ii antagonist activity

Also Published As

Publication number Publication date
JPS6317839B2 (xx) 1988-04-15
AU532335B2 (en) 1983-09-29
EP0014911A3 (en) 1980-11-26
IL59362A (en) 1982-12-31
DE2905502A1 (de) 1980-09-04
US4275001A (en) 1981-06-23
HU182067B (en) 1983-12-28
DK61180A (da) 1980-08-15
ATE2316T1 (de) 1983-02-15
ES488382A1 (es) 1980-10-01
EP0014911B1 (de) 1983-01-26
DK148085B (da) 1985-02-25
IL59362A0 (en) 1980-05-30
DE3061712D1 (en) 1983-03-03
AR227386A1 (es) 1982-10-29
JPS55111449A (en) 1980-08-28
EP0014911A2 (de) 1980-09-03
AU5548180A (en) 1980-08-21
DK148085C (da) 1985-08-12
JPS62277397A (ja) 1987-12-02
JPS6345398B2 (xx) 1988-09-09
CA1144160A (en) 1983-04-05
DE2905502C2 (de) 1982-07-15

Similar Documents

Publication Publication Date Title
JPS5346930A (en) Phenoxyyaminoopropanols and process for preparation thereof
GR63092B (en) Preparation process of untriakonta peptides
GR62565B (en) Preparation process of peptides
PT66076B (en) Positions process for the preparation of herbicide compounds and com
GB2017703B (en) Preparation of tetrahydrobenzoxocins and cishexahydrodibenzopyranones
ZA79575B (en) 1-aryloxy 3-nitratoalkylamino 2-propanols and process for their preparation
ZA80817B (en) Process for the manufacture of lh-rh and lh-rh analogs using glu-his(dnp)-oh
GR63113B (en) Preparation process of meta-aryloxybenzaldehydes
GB2058063B (en) Process for the preparation of 2-mercaptoalkyl-sulphides and 2-mercaptoalkylethers
DE2960275D1 (en) Process for the preparation of acyloxysilanes and possibly acyloxysiloxanes
DE2962925D1 (en) Process for the preparation of pure potassium ribonate and pure ribonolactone
GB1518630A (en) Indazolyl-(4)-oxy-propanolamines and process for their preparation
IL58992A (en) Guiaiacol esters of mercaptopropionylglycine(alanine),process for preparing same and therapeutical compositions comprising such esters
GR61990B (en) Preparation process of ((quinolyl-4)-3propyl-1)-4piperidines
DE3067697D1 (en) 1-azolyl-1-halogen-alkan-2-ones and process for the preparation of 1-azolyl-1-phenoxy-alkan-2-ones
IL52320A0 (en) P-isobutzyl hydratropate of guyiycol and process for its preparation
GB2012772B (en) Analogues of endorphin and a process for the preparation thereof
ZA785691B (en) Analogs of somatostatin and process for the manufacture thereof
IL52771A0 (en) Novel process for the preparation of peptides and novel carrier compounds used therein
GB2037728B (en) Process for the preparation of orthophosphorus acid and phosphine
JPS5539874A (en) Seat of autobicycle
DE2961756D1 (en) Process for the preparation of halogenobutenyl acrylates
GB1519931A (en) Process for the preparation of ethyl aminocyanoacetate
IL57817A0 (en) Dihalovinyl cyclopropylvinyl alkanoates and their preparation
GR61146B (en) Preparation process of 1-oxadethiacephalosporins analogues